Skip to Content

Notice

Proposed Data Collections Submitted for Public Comment and Recommendations

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404-639-4766 and send comments to Seleda Perryman, CDC Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov.

Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice.

Proposed Project

National Disease Surveillance Program—I. Case Reports—Revision—(NCID), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

Formal surveillance of 18 separate reportable diseases has been ongoing to meet the public demand and scientific interest in accurate, consistent, epidemiologic data. These ongoing disease reports include: Active Bacterial Core Surveillance (ABCs), Creutzfeldt-Jakob Disease (CJD), Cyclospora, Dengue, Hantavirus, Idiopathic CD4+T-lymphocytopenia, Kawasaki Syndrome, Legionellosis, Lyme disease, Malaria, Plague, Q Fever, Reye Syndrome, Tick-borne Rickettsial Disease, Trichinosis, Tularemia, Typhoid Fever, and Viral Hepatitis. Tularemia is a new addition to this submission. Case report forms from state and territorial health departments enable CDC to collect demographic, clinical, and laboratory characteristics of cases of these diseases. This information is used to direct epidemiologic investigations, identify and monitor trends in reemerging infectious diseases or emerging modes of transmission, to search for possible causes or sources of the diseases, and develop guidelines for prevention and treatment. The data collected will also be used to recommend target areas most in need of vaccinations for selected diseases and to determine development of drug resistance.

Because of the distinct nature of each of the diseases, the number of cases reported annually is different for each. There is no cost to respondents other than their time.Start Printed Page 73007

Estimate of Annualized Burden Table

FormNumber of respondentsNumber of responses per respondentTotal responsesHrs/responseTotal burden
ABCs32921690910/601152
CJD2024020/6013
Cyclospora551055015/60138
Dengue Case Investigation5518210,01015/602,503
Hantavirus Pulmonary Syndrome40312020/6040
Idiopathic CD4+T-lymphocytopenia1022010/603
Kawasaki Syndrome55844015/60110
Legionellosis Case Report2311.726920/6090
Lyme Disease Report5226120,0205/601,668
Malaria Case Surveillance Report55201,10015/60275
Plague Case Investigation Report550.201120/604
Q Fever5515510/609
Reye's Syndrome Case Surveillance Report5015020/6017
Tick-borne Rickettsial Disease Case Report551899010/60165
Trichinosis Surveillance Case Report550.703920/6013
Tularemia552.212120/6040
Typhoid Fever Surveillance Report55738520/60128
Viral Hepatitis Case Record5520011,00025/604,583
Total10,950
Start Signature

Dated: December 2, 2005.

Joan Karr,

Acting Reports Clearance Officer, Centers for Disease Control and Prevention.

End Signature End Preamble

[FR Doc. E5-7038 Filed 12-7-05; 8:45 am]

BILLING CODE 4163-18-P